TWIST BIOSCIENCE CORP's ticker is TWST and the CUSIP is 90184D100. A total of 209 filers reported holding TWIST BIOSCIENCE CORP in Q1 2022. The put-call ratio across all filers is 1.16 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $446,510 | +8.4% | 22,039 | +9.5% | 0.00% | 0.0% |
| Q2 2023 | $411,901 | +155.7% | 20,132 | +88.4% | 0.00% | – |
| Q1 2023 | $161,100 | -36.7% | 10,683 | 0.0% | 0.00% | -100.0% |
| Q4 2022 | $254,362 | +8.7% | 10,683 | +61.1% | 0.00% | 0.0% |
| Q3 2022 | $234,000 | +0.4% | 6,633 | -0.3% | 0.00% | 0.0% |
| Q2 2022 | $233,000 | +62.9% | 6,652 | +129.5% | 0.00% | 0.0% |
| Q1 2022 | $143,000 | -33.2% | 2,898 | +13.0% | 0.00% | 0.0% |
| Q4 2021 | $214,000 | -39.2% | 2,565 | -22.0% | 0.00% | -50.0% |
| Q3 2021 | $352,000 | -20.5% | 3,287 | -1.0% | 0.00% | 0.0% |
| Q2 2021 | $443,000 | +10.5% | 3,321 | +2.7% | 0.00% | -33.3% |
| Q1 2021 | $401,000 | +30.6% | 3,235 | +48.9% | 0.00% | +50.0% |
| Q4 2020 | $307,000 | -14.0% | 2,173 | -53.8% | 0.00% | -33.3% |
| Q3 2020 | $357,000 | +66.8% | 4,699 | -0.7% | 0.00% | +50.0% |
| Q2 2020 | $214,000 | – | 4,731 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tao Capital Management LP | 1,104,214 | $156,015,000 | 38.36% |
| Blue Water Life Science Advisors, LP | 146,356 | $20,678,000 | 6.16% |
| Casdin Capital, LLC | 1,000,000 | $141,290,000 | 4.19% |
| BRANDYWINE MANAGERS, LLC | 18,988 | $2,683,000 | 3.69% |
| Capital Impact Advisors, LLC | 97,000 | $13,705,000 | 3.36% |
| Brevan Howard Capital Management LP | 112,000 | $15,824,000 | 3.17% |
| ARK Investment Management | 5,876,971 | $830,357,000 | 2.21% |
| Nicholas Investment Partners, LP | 178,875 | $25,273,000 | 1.95% |
| Nikko Asset Management Americas, Inc. | 1,840,306 | $260,017,000 | 1.48% |
| Intellectus Partners, LLC | 28,058 | $3,964,000 | 1.19% |